91
Views
0
CrossRef citations to date
0
Altmetric
Review articles

Young rural people at risk for schizophrenia: Time for mental health services to translate research evidence into best practice of care

(Senior Lecturer) , (Clinical Director) , (Clinical Director) & (Associate Professor)
Pages 872-882 | Received 01 Feb 2010, Accepted 11 May 2010, Published online: 10 Oct 2010

References

  • McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, . Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 2009; 70:1206–12.
  • DSM-5. http://www.dsm5.org/ProposedRevisions/Revisions?Pages/proposedrevision.aspx?rid=412
  • Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, . Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 2007; 33:682–7.
  • Larsen TK, Melle I, Friis S, Joa I, Johannessen JO, Opjordsmoen S, . One-year effect of changing duration of untreated psychosis in a single catchment area. British Journal of Psychiatry – Supplementum 2007; 51:S128–32.
  • Carr VJ, Neil AL, Halpin SA, Holmes S, Lewin TJ, Carr VJ, . Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study. Aust N Z J Psychiatry 2003; 37:31–40.
  • Mangalore R, Knapp M, Mangalore R, Knapp M. Cost of schizophrenia in England. The Journal of Mental Health Policy & Economics 2007; 10:23–41.
  • Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998; 24:425–35.
  • McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000; 57:637–48.
  • Borgwardt SJ, McGuire PK, Aston J, Berger G, Dazzan P, Gschwandtner U, . Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. British Journal of Psychiatry – Supplementum 2007; 51:s69–75.
  • Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, . Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361:281–8.
  • Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, . Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophr Res 2009; 108:85–92.
  • Pantelis C, Yucel M, Bora E, Fornito A, Testa R, Brewer WJ, . Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target. Neuropsychological Review 2009; 19:385–398.
  • Avila MT, Sherr J, Valentine LE, Blaxton TA, Thaker GK, Avila MT, . Neurodevelopmental interactions conferring risk for schizophrenia: a study of dermatoglyphic markers in patients and relatives. Schizophr Bull 2003; 29:595–605.
  • Lloyd T, Dazzan P, Dean K, Park SB, Fearon P, Doody GA, . Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Psychol Med 2008; 38:71–7.
  • Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci 1995; 3:89–97.
  • Bullmore ET, Frangou S, Murray RM. The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophr Res 1997; 28:143–56.
  • Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jr., Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996; 53:425–36.
  • Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA, Levitt P, . Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry 2006; 60:534–7.
  • Cannon TD, Yolken R, Buka S, Torrey EF. Collaborative Study Group on the Perinatal Origins of Severe Psychiatric D, Cannon TD, . Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol Psychiatry 2008; 64:797–802.
  • Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry 1995; 167:786–93.
  • Schmidt-Kastner R, van Os J, H WMS, Schmitz C, Schmidt-Kastner R, van Os J, . Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 2006; 84:253–71.
  • Verdoux H, Sutter AL, Verdoux H, Sutter A-L. Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology. Am J Med Genet 2002; 114:898–905.
  • Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, . Common variants conferring risk of schizophrenia. Nature 2009; 460:744–7.
  • Brown AS, Susser ES. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 2008; 34:1054–63.
  • McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 1999; 40:173–7.
  • Owen MJ, Craddock N, Jablensky A, Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007; 33:905–11.
  • Murray RM, Lappin J, Di Forti M, Murray RM, Lappin J, Di Forti M. Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol 2008; 18 Suppl 3:S129–34.
  • Kapur S, Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160:13–23.
  • Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, . Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006; 49:603–15.
  • Howes OD, Kapur S, Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III—the final common pathway. Schizophr Bull 2009; 35:549–62.
  • Murotani T, Ishizuka T, Hattori S, Hashimoto R, Matsuzaki S, Yamatodani A, . High dopamine turnover in the brains of Sandy mice. Neurosci Lett 2007; 421:47–51.
  • Kubota K, Kumamoto N, Matsuzaki S, Hashimoto R, Hattori T, Okuda H, . Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Biochem Biophys Res Commun 2009; 379:191–5.
  • Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A, . Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 2009; 32:485–95.
  • Torrey EF, Buka S, Cannon TD, Goldstein JM, Seidman LJ, Liu T, . Paternal age as a risk factor for schizophrenia: How important is it? Schizophr Res 2009; 114:1–5.
  • Erlenmeyer-Kimling L. Early neurobehavioral deficits as phenotypic indicators of the schizophrenia genotype and predictors of later psychosis. Am J Med Genet 2001; 105:23–4.
  • Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML, Taylor EA, . Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9–12 years. Schizophr Res 2007; 90:130–46.
  • Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 2000; 57:1053–8.
  • Bhugra D. Migration and schizophrenia. Acta Psychiatr Scand 2000; 102:S68–73.
  • Marcelis M, Navarro-Mateu F, Murray R, Selten JP, van Os J. Urbanization and psychosis: a study of 1942–1978 birth cohorts in The Netherlands. Psychol Med 1998; 28:871–9.
  • Morgan C, Fisher H, Hutchinson G, Kirkbride J, Craig TK, Morgan K, . Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample. Acta Psychiatr Scand 2009; 119:226–35.
  • Henquet C, Murray R, Linszen D, van Os J, Henquet C, Murray R, . The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31:608–12.
  • Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE, . Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325:1212–3.
  • Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, . Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005; 57:1117–27.
  • Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M, . An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006; 31:2748–57.
  • Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annual Review of Clinical Psychology 2008; 4:189–216.
  • Thompson KN, Phillips LJ, Komesaroff P, Yuen HP, Wood SJ, Pantelis C, . Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res 2007; 41:561–9.
  • Thompson KN, Berger G, Phillips LJ, Komesaroff P, Purcell R, McGorry PD. HPA axis functioning associated with transition to psychosis: combined DEX/CRH test. J Psychiatr Res 2007; 41:446–50.
  • Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, . Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35:894–908.
  • Walker EF, Esterberg M, Brasfield J. The relation of cortisol secretion with social and role functioning deficits in CHR youth. Schizophr Bull 2009; 35 Supplement 1:322.
  • Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, . Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 2002; 59:449–56.
  • Cornblatt BA, Auther AM, Cornblatt BA, Auther AM. Treating early psychosis: who, what, and when? Dialogues Clin Neurosci 2005; 7:39–49.
  • Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, . Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability[erratum appears in Schizophr Bull. 2004;30(2):following 217]. Schizophr Bull 2003; 29:703–15.
  • Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, . Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39:964–71.
  • van Os J, Delespaul P, van Os J, Delespaul P. Toward a world consensus on prevention of schizophrenia. Dialogues Clin Neurosci 2005; 7:53–67.
  • Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58:158–64.
  • Amercian Psychiatric Association. www.psych.org
  • McGorry PD, McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 2007; 164:859–60.
  • Schizophrenia Research Forum. www.schizophreniaforum.org
  • Carpenter WT, Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull 2009; 35:841–3.
  • French P, Shryane N, Bentall RP, Lewis SW, Morrison AP. Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis. British Journal of Psychiatry – Supplementum 2007; 51:s82–7.
  • Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, . The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the “prodromal” sample. Schizophr Res 2003; 61:19–30.
  • Marshall M, Rathbone J. Early intervention for psychosis. [update of Cochrane Database Syst Rev. 2004;(2):CD004718; PMID: 15106257]. Cochrane Database Syst Rev 2006:CD004718.
  • Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, . Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004; 185:291–7.
  • McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, . Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163:790–9.
  • McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, . Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59:921–8.
  • Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, . Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67:146–54.
  • Birchwood M, Patterson P, Lester H, Singh S. Integrating UHR research and practice into the public health agenda: The Birmingham ED:IT programme. Schizophr Bull 2009; 35 Supplement 1:S134–135.
  • Lewis SW, Wykes T, David A, Marshall M, Deakin W, Szmukler G. The UK Mental Health Research Network: Large scale trials for non-drug interventions for schizophrenia. Schizophr Bull 2009; 35 Supplement 1:134.
  • NHS. Schizophrenia clinical guidelines. London: National Institute for Health and Clinical Excellence, 2009.
  • Mental Health Research Network. www.mhrn.info/index.html
  • Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P, Mihalopoulos C, . Is early intervention in psychosis cost- effective over the long term? Schizophr Bull 2009; 35:909–18.
  • Stain HJ, Crittenden K, Bennett E, Startup M, Carr V, Baker A, . The impact of geography and social context on ultra high risk for schizophrenia research in rural Australia. Schizophr Bull 2009; 35 Supplement 1:S376–377.
  • McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, . Recruitment and treatment practices for help-seeking “prodromal” patients. Schizophr Bull 2007; 33:715–26.
  • Yung AR, Phillips LJ, Yuen HP, McGorry PD, Yung AR, Phillips LJ, . Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67:131–42.
  • Bechdolf A, Phillips LJ, Francey SM, Leicester S, Morrison AP, Veith V, . Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci 2006; 256:159–73.
  • Weiser M, van Os J, Reichenberg A, Rabinowitz J, Nahon D, Kravitz E, . Social and cognitive functioning, urbanicity and risk for schizophrenia. Br J Psychiatry 2007; 191:320–4.
  • AIHW. Rural, regional and remote health. Mortality trends 1992–2003. Rural Health Series No. 7 Cat No. PHE 71. Canberra: Australian Institute of Health and Welfare, 2006.
  • Page A, Morrell S, Taylor R, Dudley M, Carter G, Page A, . Further increases in rural suicide in young Australian adults: secular trends, 1979–2003. Soc Sci Med 2007; 65:442–53.
  • Australian Institute of Health and Welfare.. Young Australians: their health and well-being 2007. Cat no PHE 87. 2007.
  • Griffiths KM, Christensen H, Jorm AF, Griffiths KM, Christensen H, Jorm AF. Mental health literacy as a function of remoteness of residence: an Australian national study. BMC Public Health 2009; 9:92.
  • Hafner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkotter J, Wagner M, . Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254:117–28.
  • McGorry PD, Yung AR, Bechdolf A, Amminger P, McGorry PD, Yung AR, . Back to the future: predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatry 2008; 65:25–7.
  • Nelson B, Simmons MB, Yung AR, Buckby JA, O'Dwyer L, Francey SM, . Identifying the ultra-high risk (prodromal) population: evaluation of training workshops with mental health services. Aust N Z J Psychiatry 2008; 42:236–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.